Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$10,470,321
-$3,274,923 QoQ
Shares Held
434,814
-11.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#414
of 2,821 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AGF MANAGEMENT LTD holds $1,321,975,737 across 10 Drug Manufacturers - General names. PFE ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
556,470 | $667,446,866 | |
| 2 | JNJ |
Johnson & Johnson
|
1,545,100 | $392,409,044 | |
| 3 | ABBV |
AbbVie Inc.
|
652,937 | $164,305,065 | |
| 4 | NVS |
Novartis AG
|
360,354 | $56,474,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
334,104 | $19,251,072 | |
| 6 | PFE |
Pfizer Inc
This page
|
434,814 | $10,470,321 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
43,538 | $5,500,590 | |
| 8 | AMGN |
Amgen Inc
|
9,492 | $3,437,243 |
All Filings in PFE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,470,321 | 434,814 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $13,745,244 | 489,503 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $12,193,902 | 489,715 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,604,440 | 847,898 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $21,757,337 | 897,580 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $28,156,869 | 1,111,163 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $31,195,140 | 1,175,844 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $36,566,007 | 1,263,511 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $34,243,070 | 1,223,841 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $31,839,710 | 1,147,377 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $28,826,015 | 1,001,251 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,959,032 | 209,799 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,980,944 | 217,583 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $24,921,251 | 610,815 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $31,138,137 | 607,692 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||